The Agilent and Atturos pathway for the development of targeted biomarker measurements for precision medicine
Personalized medicine for improved human health outcomes will depend on the availability of better clinical research tests. These tests will incorporate data from multiple protein biomarkers and combine this with existing clinical research to provide subject-specific individual ‘scores’ and inform clinical decision making.
In this expert webinar, Prof. Stephen Pennington, Dr. Orla Coleman, and Dr. James Waddington outline the significant clinical need for better chronic disease testing and explain how this need can be met through an integrated workflow that enables simplified, robust, reproducible, and cost-effective analysis of readily collected human samples. Using supporting illustrative data, these experts demonstrate how it may be possible to use clinical research measurements for precision medicine.
Key learning objectives:
- Importance of standardized, reproducible, and simplified workflows for the generation of clinical-grade protein multiple reaction monitoring (MRM) data
- Impact of routine QCs and system suitability monitoring for large-scale clinical studies
- Key role of advanced diagnostic tests based on multiplexed protein MRM data in a future of personalized medicine
Who should attend:
- Clinical lab managers
- Clinical research scientists
- Clinical researchers